
ARK Genomic Revolution ETF
ARKGBATSARKEquity
As of Nov 16, 2026 close
- Assets (AUM)
- $2.17B
- Expense ratio
- 0.75%
- Dividend yield
- -
- Holdings
- 33
- 52-week range
- $24.60$58.83
- Volume (live)
- -
- Avg. volume (3M)
- 5.81M
ARKG ETF: ARK Genomic Revolution ETF - Price, Holdings & Analysis
ARK Genomic Revolution ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $40.53 - $42.53 |
|---|---|
| 52-Week High | $58.83 |
| 52-Week Low | $24.60 |
| Open | $42.44 |
| Volume (last close) | 5.50M |
| Average Volume (3M) | 5.81M |
| 1 Day Change | −5.97% |
|---|---|
| 1 Month Change | −13.02% |
| 6 Month Change | +44.30% |
| YTD Change | +39.20% |
| 1 Year Change | +51.17% |
| 5 Year Change | −43.24% |
| 10 Year Change | +116.27% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Dec 29, 2021 |
| Assets (AUM) | $2.17B |
|---|---|
| Expense Ratio | 0.75% |
| Total Holdings | 33 |
| Inception Date | Oct 30, 2014 |
| 50-Day MA | $49.45 |
|---|---|
| 200-Day MA | $38.12 |
| RSI | 34.20 |
| Stochastic %K | 0.59 |
| Stochastic %D | 6.42 |
Source: Exchange price data and fund disclosures. Data as of Nov 16, 2026. Data sources and methodology
ARKG at a Glance
ARK Genomic Revolution ETF (ARKG) is an equity ETF from ARK, launched in October 2014. It manages $2.17B in assets and charges a 0.75% expense ratio, about $75 a year per $10,000 invested.
Based on holdings data updated Oct 4, 2026, it holds 33 positions. The largest are Twist Bioscience Corporation (TWST, 10.23%), 10x Genomics, Inc. (TXG, 10.04%) and Tempus AI, Inc. (TEM, 8.51%). The top 10 holdings make up 64.2% of the fund. By sector it leans toward Healthcare (100.0%). 90.8% of assets are in the United States.
It does not currently pay distributions. As of the Nov 16, 2026 close, the share price is up 51.2% over one year, down 43.2% over five years and up 116.3% over ten years (price change, excluding distributions).
Frequently Asked Questions About ARK Genomic Revolution ETF
What is the current price of ARKG?
The latest ARKG price is $40.62 (Nov 16, 2026 close). The 52-week range is $24.60–$58.83. The share price is up 51.2% over the past year (price change, excluding distributions).
What is the expense ratio for ARKG?
ARKG's annual expense ratio is 0.75%, about $75 a year for every $10,000 invested.
Does ARKG pay dividends?
ARK Genomic Revolution ETF has paid no distributions in the trailing 12 months to the Nov 16, 2026 close. Its most recent recorded distribution was $0.38 per share, with an ex-dividend date of December 29, 2021.
What are the top holdings of ARKG?
In holdings data last updated Oct 4, 2026, ARKG's largest holdings are Twist Bioscience Corporation (10.2%), 10x Genomics, Inc. (10.0%), Tempus AI, Inc. (8.5%) (combined weight: 28.8%). The fund holds 33 total positions. View the complete portfolio breakdown in the Holdings section.
How concentrated is ARKG's portfolio?
In holdings data updated Oct 4, 2026, the top 10 holdings make up 64.2% of ARKG's assets across 33 positions. Its largest sector weight is Healthcare at 100.0%.
How large is ARKG and when did it launch?
ARKG manages $2.17B in assets. ARK launched the fund on October 30, 2014, about 12 years before the Nov 16, 2026 close.